Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trial
待确认10由 钱钱 发布于 2026/3/11 11:34:39
DOI:10.1016/s1473-3099(24)00814-4
作者:álvaro H Borges, Marisa Russell, Dereck Tait, Thomas J Scriba, Elisa Nemes, Per Skallerup, Elana van Brakel, Andrea M Cabibbe, Daniela M Cirillo, Mildie Leuvennink-Steyn, Kathryn T Rutkowski, Grith K
文献类型:期刊论文
补充材料:只需要正文